KATHERINE EBERHARDT: Open Payments
NPI 1790450492 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 46 payments from 10 companies in 2025. Trend: 2023 $412 · 2024 $293 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 29 | $204 |
| Novo Nordisk Inc | 4 | $176 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $136 |
| Lilly USA, LLC | 2 | $131 |
| Cleerly, Inc. | 1 | $50 |
| BridgeBio Pharma, Inc. | 3 | $50 |
| Amgen Inc. | 2 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: LEQVIO, JARDIANCE, Ozempic, ZEPBOUND, Cleerly Ischemia, Attruby, Wegovy, REPATHA.
Industry payments across NY — which companies pay providers there.
